블로그
- FDA] FDA Approves First Gene Therapy for Young Children with Sickle Cell Disease for Casgevy (exagamglogene autotemcel) for patients aged 2 years and older with either sickle cell disease This is the first gene therapy approved for patients aged 2 years and older with SCD.
- [U.S. FDA] FDA Approves First Drug to Treat the Full Range of Narcolepsy Type 1 Symptoms Orzeyful is the first medicine approved for narcolepsy type 1 as a complete disorder — addressing the of orexin signaling that causes the disease.
- [U.S. FDA] FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Dise nutritional management in adults and pediatric patients 8 years of age and older with glycogen storage disease Genglycos is the first approved treatment for this condition. The accelerated appro.......
- [U.S. FDA] FDA Approves New Treatment That Uses Donor Immune Cells to Prevent Serious Complications Food and Drug Administration today approved Tregzi, the first regulatory T (Treg) cell-based immunotherapy for improving chronic graft-versus-host disease (GVHD)-free survival in adult patients with blood cancers
- 수국 화단에 옮겨심기 수국 구매 #1.Vanilla Strawberry Panicle Hydrangea #2.flowerfull smooth hydrangea, First Editions The FlowerFull Disease Resistance: Dark green, lush folia.......
- Sharp Rise in Stomach Illnesses as Temperatures Climb Weekly cases nationwide have surpassed 700 for the first time in nearly three months, raising concerns According to the latest data from the Korea Disease Control and Prevention Agency, 733 cases of stomach
- {daily stoic 스토아철학} April 23rd_the mind is all yours_the mind alone is truly yours yours_the mind alone is truly yours you have been formed of three parts body breath and kind of these, the first YOURS 그러니 간수 잘해 함부로 두지말라고 상처받게말고 내버려두지말고 물주고 거기에 긍정 씨앗키워주고 비료도 팍팍 부어주고 the body can be ravaged by disease
- [파스퇴르 네트워크] 2025년 7월 뉴스레터 office at the Institut Pasteur de Dakar - Fiocruz coordinates priority initiatives within the BRICS - First Against H5N1 - Eradicating One Species to Help Others: A Debate on Gene Editing to Control Pests and Disease
- Phase III Trial Results Suggest a New Standard of Care in Metastatic HER2-Positive Breast Cancer Standard of Care in Metastatic HER2-Positive Breast Cancer In the phase III DESTINY-Breast09 trial, first-line progression by more than 1 year—nearly doubling the time of disease control—over standard treatment
- [2025년 7월 고3 모의고사 영어] 23번 주제 추론 지문 분석과 변형 문제 & 중요 구문 정리 First, until very recently, research on wild animal disease has been an underestimated field of......
1 페이지
다음 →